Leverage Shares 3x Long Moderna (MRNA) ETC (3MRE.L) Price
Leverage Shares 3x Long Moderna (MRNA) ETC Price
Underlying
Leverage Shares 3x Long Moderna (MRNA) ETC provides 3X daily exposure to MRNA.
Leverage & Compounding Risk
This ETF rebalances daily to achieve its 3X target. Over periods longer than one day, compounding can cause returns to deviate significantly from 3X the underlying's return — especially in volatile, sideways markets (volatility decay). This product is designed for short-term trading, not buy-and-hold investing.
Leverage Shares 3x Long Moderna (MRNA) ETC List of Holdings
Frequently asked questions about Leverage Shares 3x Long Moderna (MRNA) ETC
Leverage Shares 3x Long Moderna (MRNA) ETC is offered by LeverageShares, a leading player in the field of passive investments.
The ISIN of Leverage Shares 3x Long Moderna (MRNA) ETC is XS2675718725.
Leverage Shares 3x Long Moderna (MRNA) ETC aims to deliver 3 times the daily return of MRNA (long). The leverage resets each trading day, so multi-day returns can differ materially from 3X the underlying's cumulative return.
Volatility decay (also called compounding drag) occurs because Leverage Shares 3x Long Moderna (MRNA) ETC rebalances daily. In choppy, sideways markets the cumulative return can significantly trail 3X the underlying's period return — even if the underlying ends flat. The effect intensifies with higher leverage factors and longer holding periods.
Leveraged ETFs like Leverage Shares 3x Long Moderna (MRNA) ETC are designed for short-term, tactical trading — typically intraday or a few days. Holding them for weeks or months exposes investors to compounding risk and potential tracking deviation. Most issuers explicitly recommend against long-term holding.
Leverage Shares 3x Long Moderna (MRNA) ETC provides 3X daily long exposure to MRNA. When MRNA moves +1% in a day, Leverage Shares 3x Long Moderna (MRNA) ETC targets approximately 3% (before fees).
The ETF is listed in EUR.
European investors may incur additional costs for currency exchange and transaction fees.
No, Leverage Shares 3x Long Moderna (MRNA) ETC does not comply with the EU UCITS investor protection directives.
The current average trading volume of Leverage Shares 3x Long Moderna (MRNA) ETC is 157,229.00.
The fund was launched on 12/15/2021.
Investments can be made through brokers or financial institutions that provide access to trading ETFs.
The ETF is traded on the stock exchange, similar to stocks.
Yes, the ETF can be held in a regular securities account.
The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.
The ETF is valued on a daily stock exchange basis.
Information on dividends should be requested from the provider's website or your broker.
The risks include market fluctuations, currency risks, and the risk associated with smaller companies.
The ETF is obligated to report regularly and transparently on its investments.
The performance can be viewed on Eulerpool or directly on the provider's website.
Further information can be found on the official website of the provider.
ETF profile
Leverage Shares 3x Long Moderna (MRNA) ETC